BOSTON (PRWEB) November 01, 2017
The Institute for Pediatric Innovation (IPI) is proud to announce that it has been the recipient of a grant from the New England Pediatric Device Consortium (NEPDC) for ShapeTape, a pre-cut therapeutic kinesiology tape used to stabilize the ET tube to reduce the occurrence of unplanned extubations (UEs).
The award will go towards obtaining clinician input and expertise to determine the optimal product shapes and sizes. Additionally, the grant will be used to analyze potential commercial partners.
ShapeTape was developed by participants in IPI’s Clinical Innovation Catalyst Program which is run collaboratively with four pediatric hospital partners— Shriners Hospital for Children Northern California, Stanford Children’s Health, Texas Children’s Hospital, and University Hospitals Rainbow Babies & Children’s Hospital. During each Catalyst program cycle, the Hospital Consortium chooses a hospital acquired condition on which to focus. The hospitals chose UEs as the 2016-2017 focus.
UEs are one of the most common adverse events in neonatal intensive care units. Sometimes, patient movement can cause unplanned UEs which is when these tubes become dislodged or removed, potentially resulting in prolonged treatment or life-threatening situations or sometimes death. In addition to additional treatment time and potential airway trauma, these conditions can add an average of 6.5 days to a hospital stay and up to $37,000 per case in pediatrics.
ShapeTape, a durable tape adapted from other healthcare uses, is specially pre-cut to adapt to a baby’s face and withstands patient movement and adverse environments. Since ShapeTape will hold for multiple days and be resistant to moisture, it will reduce the number of times the ET tube needs to be re-taped compared to standard cloth medical tape.
Catalyst participants assessed the business opportunity, noting its lower cost against competitors and potential to decrease UEs by 20%.
The product was one of three products developed in the last Catalyst cycle.
The Institute for Pediatric Innovation (IPI) was founded as a nonprofit 501(c)3 corporation in 2006. The institute is managed and led by a consortium of pediatric hospitals, who, together with IPI staff, provide deep expertise in pediatric medical device and medicine innovation. IPI is managed and led by a consortium of pediatric hospitals from around the United States. Their expertise is joined by experts from all sectors to identify problem areas and create novel solutions and a worldwide network of collaborators to assist in translating innovations into commercially available solutions.